Acarix
0.31 SEK
+1.81 %
Less than 1K followers
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+1.81 %
+15.92 %
+3.17 %
+28.96 %
+23.31 %
+16.79 %
+10.05 %
-77.64 %
-95.81 %
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.
Read moreMarket cap
347.67M SEK
Turnover
158.28K SEK
Revenue
6.2M
EBIT %
-1,070.48 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/2
2026
Annual report '25
All
Press releases
ShowingAll content types
Acarix AB (publ) publicerar tredje kvartalet 2025
Acarix Publishes Interim Report, Third quarter 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools